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Sherwin B. Nuland, surgeon and bioethicist wrote To become comfortable with uncertainty 
is o e of the pri ary goals i  the trai i g of a physicia . (1)  Whether we are comfortable 
with it or not, uncertainty is a feature of our work.  We are rarely certain about the risk and 
benefits of therapy, we struggle to estimate prognosis and, often, diagnoses are elusive.  
We use clinical and laboratory information to try to reduce this uncertainty.  
 
In this context is it worth remembering what i for atio ’ means formally.  Claude 
Shannon, a mathematician and the father of Information Theory, defined it as a measure of 
the number of possible alternatives.  (2) The its  that we ou t i  their billions in our 
devices are choices between two states: 0 and 1  or true  a d false . The bit is therefore 
the lowest possible unit of information. In other words, there is o i for atio  without a  
alternative.   
 
Intensivists face a huge number of potential alternatives. Acquisition of information reduces 
this number of potential states - resolving some uncertainty. Inherited genetic disease is an 
example where the number of alternative states is both large and, as yet, not fully defined. 
The On-line Medelian Inheritance in Man (OMIM) database (https://www.omim.org) as of 
15th June 2019 lists more than 7,000 phenotypes and 16,092 genes. Traditional approaches 
of testing for a focussed panel of genes based on phenotype, requires the expertise from 
our clinical genetics colleagues.  Their expertise is information that reduces this huge 
number of alternatives. However, we often do not make diagnoses in our patients despite 
high levels of suspicion of a genetic basis for disease. 
 
An alternative approach, is the more brute force  approach to collecting information of 
whole genome sequencing. (3-7) 
 
In this issue of the journal Wu et al describe such an approach to genetic diagnosis in 
undiagnosed critically-ill children and newborns in Taiwan. (8) They used whole exome 
sequencing in 40 children and newborns with suspected genetic disease to obtain 50-
100,000 variants.  Eleven of the 40 (27.5%) were diagnosed with previously reported 
mutations and another 8 had strong pointers to a new diagnosis. Mean time to a diagnosis 
was 6.2 days (range 4.3-9).   When describing these new diagnoses, the authors state: Many 
were [the] first example of these diseases recognized in Taiwan.   
 
This suggests an extraordinary powerful diagnostic technique – to identify diseases that the 
clinical staff may not be considering. Humans are biased by personal experience more than 
formal probabilities.  I  Bayesia  ter s the prior pro a ility  of these diseases as assessed 
by the team will have been low.  The post-test probability is extremely high.  We rarely have 
the benefit of such extreme modification of the odds of a disease by a single result.  The 
second important observation in the paper is that the information obtained by this 
technique often had value.  The diagnostic information reduced the alternatives states so 
far as to prompt a change in therapy, or goals of care, in 10 cases.  
 
Before we offer up our clinical ge eti ists  olleagues  salaries as possible cost-savings, we 
should consider the potential sources of bias in this approach. Individual patients are 
selected for testing.  The criteria applied by Wu et al: suspicion of a genetic condition in 
critically ill children (or newborns at screening), are wide.  The level of suspicion will vary 
between observers based on personality and experience. This might include a judgement of 
how abnormal a plasma ammonia level is in a sick newborn.  This judgement will change 
with time. The background genetic diversity of the study population will also influence 
performance.  Taiwanese results might not be reproduced in London, Philadelphia or Cape 
Town. 
 
The choice of WES – examining the coding element of the genome only – rather than its big 
brother: whole genome sequencing (WGS) is a potential source of bias.  A recent review 
concluded that fro  a cli ical / tech ical point of view, WGS is the better[approa h]  i  
that it provides more complete coverage of the genome. (9) Both techniques present a 
challenge of how to filter tens of thousands (WES) to millions of variants (WGS) down to the 
specific ones causing disease. This filtering cascade is subject to bias given our incomplete 
understanding of rare disease genetics.  
 
Most known rare disease genes result from the identification of pathogenic coding variants. 
We can annotate and interpret these coding protei -alteri g  variants accurately.   Analysis 
of large public genetic databases allows us to estimate these allele frequencies. Hence we 
can remove common variants since these are not compatible with the rare incidence of the 
disease.  Combining just these two filters (protein-altering and rare frequency) removes 
>95% of the variants generated in most WGS studies.  
 
Having parental data available permits further filtering on inheritance patterns. Finally, a 
panel is applied so that only variants within genes thought to be relevant to the phenotype 
are evaluated. This can be a powerful filter but also a potential major source of bias. Wu at 
al describe a text-mining approach to phenotyping with few details but including putting 
descriptive key words into pubmed. This prone to human selection and representation bias 
– where features of our own mental model of a genetic condition are more likely to be 
searched for. A more objective approach might be the use of artificial intelligence led 
scanning of patie t s health-data to focus on a bespoke gene panel. This method has 
reported some success. (10) 
 
 Even with optimal WGS filtering, diagnostic rates are typically <50%.   To improve this, we 
will have to devise additional methods to explore our data. The ways to do this are 
exhaustive but include annotation of the non-coding (98% of the total) genome, 
consideration of polygenic causations (11) and accurate identification of complex structural 
variants (12). 
 
We have never had so much information available to us.  We can resolve more uncertainty 
than ever before to benefit of many of our patients.  At the same time, we are increasingly 
aware of how little we know; we can see a little more clearly the true scale of the residual 
uncertainty.  Managing this remains our biggest challenge. 
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